News

Despite current headwinds like tariffs and patent expirations, I see long-term opportunity in top-tier pharmaceutical stocks ...
OpenSecrets reports the pharma industry led lobbying in Q2 2025, spending $105.4 million, followed by Ballard Partners at $20 million.
From rising tariffs and stricter regulations to the increasing complexity of global sourcing, pharmaceutical importers are ...
Nomura’s June 2025 analysis shows Indian pharma majors like Sun Pharma, Dr. Reddy’s, Cipla, Lupin, and Zydus posting strong ...
Pharmexcil and Mexican Consulate join hands to chart new avenues for Indian pharma expansion: Shardul Nautiyal, Mumbai Tuesday, August 12, 2025, 08:00 Hrs [IST] In a bid to unlock ...
As tariffs on drug imports from the EU look set to alter pricing and manufacturing strategies, each entity needs to study its full impact.
Thermoplastic elastomers (TPE) offer a PFAS-free solution for stoppers in parenteral packaging, ensuring a safer and more ...
Trump’s main effort, which he cited on August 3, centers on getting drugmakers to offer the same price in the US as they do ...
FOPE with CIPI team-ups with DCGI to foster dialogue and bolster collaboration with pharma sector: Our Bureau, Bengaluru Monday, August 11, 2025, 13:30 Hrs [IST] Federation of Pha ...
May & Baker is expanding its pharmaceutical operations with a facility in Anambra State to boost local medication production ...